Xyntha (Wyeth BioPharma Division of Wyeth Pharmaceuticals Inc., a subsidiary of Pfizer Inc.)
Welcome to the PulseAid listing for the Xyntha drug offered from Wyeth BioPharma Division of Wyeth Pharmaceuticals Inc., a subsidiary of Pfizer Inc.. This pharmaceutical is classified as a PLASMA DERIVATIVE. Below, you can view details for this drug, such as its dosage form, route of delivery, start market/end market dates, and more. We have also randomly listed additional pharmaceuticals used in the same PLASMA DERIVATIVE drug type category.
| LABELER NAME / MANUFACTURER: | Wyeth BioPharma Division of Wyeth Pharmaceuticals Inc., a subsidiary of Pfizer Inc. |
| NON-PROPRIETARY NAME: | antihemophilic factor (recombinant) |
| SUBSTANCE NAME: | |
| TYPE: | PLASMA DERIVATIVE |
| PHARMA CLASS: | |
| ROUTE: | |
| DOSAGE FORM: | KIT |
| MARKETING CATEGORY NAME: | BLA |
| START MARKETING DATE: | 2008-08-01 |
| END MARKETING DATE: | 0000-00-00 |
Xyntha PLASMA DERIVATIVE Details:
| Item Description | Xyntha from Wyeth BioPharma Division of Wyeth Pharmaceuticals Inc., a subsidiary of Pfizer Inc. |
| LABELER NAME: | Wyeth BioPharma Division of Wyeth Pharmaceuticals Inc., a subsidiary of Pfizer Inc. |
| DEA SCHEDULE: | |
| ACTIVE STRENGTH: | () |
| START MARKETING DATE: | 2008-08-01 |
| END MARKETING DATE: | 0000-00-00 |
| PRODUCT ID: | 58394-012_72acb4c2-2341-4297-926e-f03c01a4a379 |
| PRODUCT NDC: | 58394-012 |
| APPLICATION NUMBER: | BLA125264 |